Originally published In Press as doi:10.1074/jbc.M201229200 on February 14, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14681-14687, April 26, 2002
The Calmodulin-binding Domain of the Catalytic
Subunit of
Phosphorylase Kinase Interacts with Its Inhibitory
Subunit
EVIDENCE FOR A Ca2+-SENSITIVE NETWORK OF
QUATERNARY INTERACTIONS*
Nancy A.
Rice
,
Owen W.
Nadeau,
Qing
Yang§, and
Gerald M.
Carlson¶
From the Division of Molecular Biology and Biochemistry, School of
Biological Sciences, University of Missouri,
Kansas City, Missouri 64110-2499
Received for publication, February 6, 2002
 |
ABSTRACT |
Chemical cross-linking as a probe of
conformation has consistently shown that activators, including
Ca2+ ions, of the (


)4
phosphorylase kinase holoenzyme (PhK) alter the interactions between
its regulatory
and catalytic
subunits. The
subunit is also
known to interact with the
subunit, an endogenous molecule of
calmodulin that mediates the activation of PhK by Ca2+
ions. In this study, we have used two-hybrid screening and chemical cross-linking to dissect the regulatory quaternary interactions involving these subunits. The yeast two-hybrid system indicated that
regions near the C termini of the
(residues 343-386) and
(residues 1060-1237) subunits interact. The association of this region
of
with
was corroborated by the isolation of a cross-linked fragment of
containing residues 1015-1237 from an 

dimer that had been formed within the PhK holoenzyme by formaldehyde, a
nearly zero-length cross-linker. Because the region of
that we
found to interact with
has previously been shown to contain a high
affinity binding site for calmodulin (Dasgupta, M., Honeycutt, T., and
Blumenthal, D. K. (1989) J. Biol. Chem. 264, 17156-17163), we tested the influence of Ca2+ on the
conformation of the
subunit and found that the region of
that
interacts with
was, in fact, perturbed by Ca2+. The
results herein support the existence of a Ca2+-sensitive
communication network among the
,
, and
subunits, with the
regulatory domain of
being the primary mediator. The similarity of
such a Ca2+-dependent network to the
interactions among troponin C, troponin I, and actin is discussed in
light of the known structural and functional similarities between
troponin I and the
subunit of PhK.
 |
INTRODUCTION |
Phosphorylase kinase (PhK)1, a
Ca2+-dependent enzyme
involved in the regulation of
glycogenolysis, is among the largest and most complex enzymes known.
Structurally, PhK is composed of four copies each of four different
subunits, (


)4 and has a mass of 1.3 × 106 Da (for reviews see Refs. 1-3). Of the four subunits,
is catalytic, whereas the remaining three are regulatory:
and
exert quaternary constraint on the activity of
, and
is an
intrinsic molecule of calmodulin (CaM). To fully understand how PhK
integrates diverse physiological signals to regulate glycogenolytic
flux in skeletal muscle, it is first essential to understand how
intrasubunit and intersubunit interactions within the hexadecameric
holoenzyme change in response to effector ligands, and in so doing,
control its catalytic activity. Despite the increased availability of structural information regarding PhK, interactions associated with
activation and involving specific regions of individual subunits, in
particular the
and
subunits, have largely remained
uncharacterized. In this study, we have focused on delineating
interacting regions between the large
and catalytic
subunits to
advance our understanding of how structural perturbations correlate
with activation of this complex holoenzyme.
By using chemical cross-linkers as structural probes, alterations in
the interactions between the regulatory
and catalytic
subunits
of PhK consistently emerge as a common structural marker of enzyme
activation by multiple effectors, including Ca2+ ions
(4-7). Although there have been many studies on the activation of PhK
by Ca2+, it has not been clear how the binding of
Ca2+ to the
subunit (CaM) relays structural information
to the remainder of the holoenzyme, especially to the
subunit. It
has been shown that Ca2+ increases the accessibility of
specific regions of the
subunit (5), and the C-terminal region of
the
subunit has been shown by a variety of experimental approaches
to contain the regulatory domain that binds
(8-11), thus
conferring Ca2+-sensitivity to the holoenzyme. In fact,
truncation of
to eliminate this regulatory domain renders it
constitutively active by itself and Ca2+/CaM-independent
(9, 11). Our findings reported herein suggest that the flow of
structural information from
to
in the holoenzyme is directly
mediated by the C-terminal regulatory domain of
. These are the
first results to define a specific region of
that interacts with
any region of either the
or
subunits of PhK. Furthermore, the
finding that the region of
-
interaction includes a portion of
the CaM binding domain of
provides a possible explanation for the
previously observed changes in
-
interactions induced by
Ca2+.
 |
EXPERIMENTAL PROCEDURES |
Yeast and Bacterial Strains--
Saccharomyces
cerevisiae strain EGY48 (MAT
, his3,
trp1, ura3, LexAop-LEU2)
(CLONTECH) was used for all two-hybrid analyses (12). All plasmid manipulations were performed according to standard
protocol in the Escherichia coli strain DH5
, unless otherwise specified (13, 14).
Proteins and Enzymes--
Nonactivated PhK was purified from
fast-twitch skeletal muscle of New Zealand White rabbits (15), dialyzed
against 50 mM Hepes (pH 6.8), 10% sucrose, and 0.2 mM EDTA and either used immediately or stored frozen at
80 °C. The full-length
subunit was purified from isolated
holoenzyme by the method of Paudel and Carlson (16). Purified yeast and
bovine brain CaM were generously provided by Drs. Trisha M. Davis
(University of Washington) and Shengli Huang (University of Missouri
Kansas City), respectively. Glycogen phosphorylase-b (P-b) was isolated from rabbit skeletal muscle as described
(17), and residual AMP was removed with activated charcoal. The
concentrations of the isolated
subunit and the two CaM isoforms
were determined by the Bio-Rad protein assay with BSA as standard;
P-b and PhK concentrations were determined
spectrophotometrically by their respective absorbance indices (18, 19).
Anti-PhK
,
and
subunit-specific mAbs were those previously
described (20, 21). Anti-CaM was purchased from Signal Transduction
Laboratories; all other detection conjugates were from Southern Biotechnology.
Two-hybrid Plasmid Construction--
All PhK
constructs were
engineered as previously described (22). Rabbit skeletal muscle PhK
cDNA was kindly provided by Dr. Donald J. Graves (Iowa State
University) and used as the template for the preparation of all
constructs. The cDNA fragments were ligated either to pLexA
(CLONTECH), a 2-µ HIS3 plasmid, to generate a fusion protein consisting of the DNA BD (amino acids 1-202) of LexA fused to PhK
or to pB42AD
(CLONTECH), a 2-µ TRP1 plasmid, to
produce a B42 AD protein fused to PhK
. Constructs
65C,
110C,
and
FL were directionally engineered into the
EcoRI-BamHI restriction sites of pLexA by
subcloning from previously prepared constructs in plasmid pGAD424.
Subsequently, these three constructs were linearized from pLexA by
digestion with EcoRI and XhoI restriction enzymes
and ligated to pB42AD. Constructs
150C,
205C,
300C, and
342C were generated by PCR using primers to yield cDNAs flanked 5' and 3' with EcoRI and BamHI restriction sites,
respectively (sense-strand, 5'-TGAATTCACCCGCGACGCGGCA-3'; antisense
strand, (
150) 5'-ATGGATCCTTACAGGTCCCGATGCAC-3', (
205)
5'-ATGGATCCTTAGCCTGGGTGGTTGTC-3', (
300)
5'-ATGGATCCTTAGGGGCTGAAGTGGC-3', (
342)
5'-ATGGATCCTTACAGAGGTCGGAGGGC-3') and ligated to the EcoRI
and BamHI sites of pLexA. To prepare the corresponding
pB42AD
constructs, pLexA
150C, pLexA
205C, pLexA
300C, and
pLexA
342C were digested with EcoRI and XhoI, and the corresponding linear
fragments were purified and subcloned into pB42AD. Fragments of
corresponding to its regulatory tail were
generated by PCR using the following primers and ligated into both
pLexA and pB42AD at EcoRI sites: sense strands,
(
301N) 5'-TGAATTCCGGGGGAAGTTCAAGGT-3' and (
343N)
5'-TGAATTCCGCCGCCTCATCGACG-3'; antisense strand,
5'-TGAATTCTTAGTAGTCATCCTCAGCCAG-3'. The orientation and proper sequence
of all LexA and B42
fusion proteins were verified by dideoxy
sequencing and/or restriction mapping.
-
Interactions by Two-hybrid Screening--
To screen for
-
interactions, two series of C-terminal deletion mutants of the
and
subunits were assayed for interactions as LexA and B42
fusion proteins in all possible binary combinations. Yeast strain
EGY48, possessing the pSH18-34 lacZ reporter plasmid, was transformed
by a modified lithium acetate procedure as previously described (23),
and transformants were grown at 30 °C on synthetic medium
lacking histidine, tryptophan, and uracil (SD
His
Trp
Ura) for 3 days. Protein expression of all
and
constructs was verified by
Western analysis, with minor modification, as previously described (24)
using either a DNA BD cross-reactive LexA polyclonal Ab (kindly
provided by Dr. Erica Golemis, Fox Chase Cancer Center) or an AD
cross-reactive hemagglutinin mAb (Roche Molecular Biochemicals). Positive associations between
and
constructs were monitored by
transcriptional activation of the LEU2 gene by growth on defined media
lacking leucine (Leu
) and of the lacZ reporter gene by
liquid
-galactosidase assays using o-nitrophenyl
galactopyranoside as substrate (22, 25).
Two-hybrid Library Screening--
A rabbit skeletal muscle
cDNA library (22) was used to screen for interactors of PhK
by
using
300C and
FL constructs (described above) as bait. Yeast
library transformants containing either of the DNA-BD bait plasmids and
the AD cDNA library were generated as previously described (22).
Transformation efficiencies of the library for both
300C and
FL
were 104 colony-forming units/µg DNA with 9.5 × 106 and 5.4 × 106 total library clones
eventually being amplified, respectively. All transformants were pooled
and stored at
80 °C. Library screens were performed on SD/Gal/Raf
(
His,
Trp,
Ura,
Leu) synthetic media in the presence of 80 µg/ml 5-bromo-4-chloro-3-indoyl-
-D-galactopyranoside in order to simultaneously screen for galactose-dependent
LacZ expressing cDNA-encoded proteins that interact with either of the two bait proteins. After colonies were grown at 30 °C for 3-7
days, putative primary LacZ+/Leu+ colonies were restreaked onto
SD
His,
Trp,
Ura and subjected to secondary and tertiary analyses as previously described (22). Specific interactor cDNAs were ultimately identified by dideoxy sequencing.
Renaturation of the His-Trp Complex--
The isolated
subunit in 8 M urea, 0.1 M
H3PO4, 0.1 mM EDTA, and 1 mM DTT was renatured as previously described (26, 27) in
the presence of either yeast or bovine brain CaM. Each renaturation, carried out at 4 °C overnight, contained the following final
concentrations: 0.125 µM isolated
, 0.31-3.0
µM CaM, 1.66 mg/ml BSA, 0.8 M urea, 10 mM H3PO4, 0.1 mM EDTA,
0.5 mM CaCl2, 0.3 mM DTT, and 100 mM Hepes (pH 8.0).
Enzymatic Assays of the
/CaM Complex--
The activity of the
renatured
/CaM complex was determined by following the incorporation
of 32P into P-b at pH 7.0 using the filter paper
assay of Reimann et al. (28). Prior to assaying, each
renaturation sample was diluted 10-fold with buffer containing 100 mM Hepes (pH 7.0), 0.2 mM DTT, 0.5 mM CaCl2, 0.1 mM EDTA, and 1 mg/ml
BSA. To initiate the reaction, one volume of this diluted solution was
added to three volumes of reaction mixture. Final concentrations in the
standard assay were: 3.1 nM isolated
, 0.67 mM CaCl2, 10 mM
Mg(CH3CO2)2, 0.5 mM
[
-32P]ATP, 100 mM Hepes (pH 7.0), 7.8-75
nM CaM, 0.3 mg/ml BSA, 2.8 mg/ml P-b, 20 mM urea, 25 µM EDTA, 0.75 µM
DTT, and 0.25 mM H3PO4.
Cross-linking of PhK by Formaldehyde--
PhK was cross-linked
by formaldehyde (5 mM), prepared by the hydrolysis of
paraformaldehyde (29), either alone or in the presence of
Ca2+. The final concentrations in the standard
cross-linking reaction were: PhK (0.43 µM), Hepes (35 mM, pH 6.8), Ca2+ (1.25 mM), and
EDTA (1 mM). Following cross-linking, reactions were
quenched by an equal volume of SDS buffer (0.125 M Tris (pH 6.8), 20% glycerol, 5%
-mercaptoethanol, 4% SDS). Cross-linked conjugates were resolved on SDS-PAGE gradient gels (4-20%) and characterized by their apparent mass and cross-reactivity against subunit-specific mAbs (20, 21).
Partial Proteolysis of Native, Ca2+-activated, and
Cross-linked PhK--
PhK, either in the absence or presence of 1.25 mM Ca2+, was digested with chymotrypsin under
conditions that promoted selective cleavage of the
subunit. The
standard proteolysis reaction, containing 0.43 µM PhK,
0.12 µg/ml chymotrypsin, 39 mM Hepes (pH 6.8), and 1 mM EDTA, was carried out for 10 min at 30 °C and
subsequently quenched by 2× SDS buffer with brief mixing and heating
at 80 °C. Samples were resolved by SDS-PAGE on a 4-20% gradient
gel, stained with Coomassie blue, and characterized by their apparent mass. The extent of
subunit digestion, which was linear over the
time period used, and of the corresponding formation of proteolytic fragments were determined by optical integrated densitometry of the
appropriate protein bands.
To localize the region of
cross-linked to
by formaldehyde, PhK
was cross-linked as described above, but with the reaction quenched by
addition of 1 M Tris (final concentration of 100 mM) and subsequently digested by chymotrypsin (0.5 µg/ml). The subunit composition of cross-linked species was
determined by Western blotting and peptide sequencing. For sequencing,
samples were electrophoretically transferred to polyvinylidene
difluoride membranes in 10 mM
3-(cyclohexylamino)propanesulfonic acid (pH 11)/10% ethanol and
stained with amido black for visualization. Bands of interest were
excised and submitted for amino acid analysis and N-terminal sequencing
to the Harvard Microchemistry Facility.
 |
RESULTS |
The C Terminus of PhK
Interacts with the Regulatory
Domain of
in the Yeast Two-hybrid System--
Our laboratory has
previously demonstrated the formation of
-
complexes through
chemical cross-linking of the PhK holoenzyme (4-7); however,
relatively long cross-linkers were used in those studies, and as a
result, it was not unequivocally established that the
and
subunits within the hexadecameric holoenzyme actually interact, as
opposed to simply being proximal. To determine whether the observed
cross-linking of
with
results from the actual association of
these two subunits, and if so, to define the regions involved in that
interaction, we screened a series of C-terminal truncations of
and
(Fig. 1) against one another in the
yeast two-hybrid system. To avoid potential disruption of secondary
structural elements, the truncated mutants were designed based upon the
known crystal structure of the catalytic domain of the
subunit (30)
and the predicted secondary structure of the
subunit. When all
binary combinations of the
and
constructs were assayed against
each other, no interactions were observed for any C-terminal truncation
of either
or
; a significant interaction did occur,
however, when full-length constructs of both subunits were
expressed (Table I). High levels of
-galactosidase activity were induced by the interaction of
FL and
FL as either BD or AD fusions, but with the pair BD-
FL/AD-
FL
demonstrating
-galactosidase activity 3.4-fold greater than that
observed with the reciprocal combination of constructs (133 versus 39.3 Miller units). Such domain effects are not
uncommon in two-hybrid screens and have been observed with many
proteins, including the transcriptional regulators Myc and Max
(31).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
PhK and
subunit deletion mutants. A, PhK
deletion mutants. Constructs were engineered as either
transcriptional DNA BD LexA or AD BD42 fusion proteins as described
under "Experimental Procedures." Amino acid numbers are given
above the first construct. Constructs are named as subunit
followed by either the last C-terminal residue expressed beginning from
residue 1 (e.g. 305C is a fusion protein of amino acids
1-305 of the subunit) or by the first N-terminal residue expressed
ending with the final amino acid of (1237) (e.g.
1015N is a fusion protein of amino acids 1015-1237 of ).
Functionally significant domains are represented by the various
patterns as follows: gray, region missing in ' (50);
hatched, region missing in (51); and black
and white, leucine zipper. B, PhK deletion
mutants. Constructs were engineered as described under "Experimental
Procedures" and labeled as described in A. Sequence
domains are represented by the various patterns as follows:
checkered, unique N-terminal region; gray, hinge
region; hatched, C-terminal regulatory domain; and
black, CaM binding domains.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Domain mapping of and interactions
-Galactosidase activity from yeast lysates was determined using
nitrophenyl galactopyranoside as substrate. Activity is expressed as
Miller units according the following formula: A420 × 1000/(volume)(time)(A600). Data represent the
mean ± S.E. of three assays performed in duplicate. A positive
interaction is determined as being significantly greater than all
control values. NT = not tested.
|
|
The fact that none of the C-terminal deletions, but only the
full-length
and
constructs, interacted suggested that regions near the C termini of both subunits (residues 1060-1237 of
and 343-386 of
) are those that interact to form the
-
complex. To test this hypothesis, two constructs comprising either the entire
C-terminal tail of
, amino acids 301-386 (
301N), or the shorter
region therein implicated by deletion analysis to interact with
,
amino acids 343-386 (
343N), were engineered as both DNA BD and AD
fusion constructs and screened against all
subunit constructs (Fig.
1). Significant interactions were observed only between the
343N
construct and the full-length
subunit, as either DNA BD or AD
fusion proteins (14.0 and 23.6 Miller units, Table I) agreeing with the
implied region of association between
and
from the truncation
analyses. The reason why the longer
construct (
301N) did not
interact with any
construct is unclear. It should be noted,
however, that in interpreting two-hybrid data, each BD and AD fusion
protein is unique and must be evaluated as such; for instance, it is
possible that the longer construct, but not the shorter, resulted in a
chimeric protein structure in which the interaction of LexA with its
targets was sterically blocked. Similar to the results obtained with
301N, when a construct expressing only the C terminus of
(residues 1015-1237 (
1015N)) was screened as both a DNA BD and AD
fusion protein against all of the
constructs shown in Fig. 1, no
interactions were observed with any
mutant regardless of the
transcriptional domain (data not shown). However, as is described
below, a slightly shorter
1031N construct was found to interact with
FL.
Additional evidence that the C-terminal CaM-binding regulatory domain
of the
subunit interacts with the C-terminal region of the
regulatory
subunit came from screening a rabbit skeletal muscle
cDNA library (22) using
FL versus
300C BD fusions
as bait. Of ~6 × 107 library transformants screened
with
FL, 165 primary LacZ+/Leu+ colonies were obtained. Of these
initial positives, 63 were selected for further analysis, and 21 library cDNAs were ultimately sequenced. The sequencing results
showed every single one of these 21 clones to be overlapping
transcripts of the
subunit of PhK containing its entire C terminus,
but varying in N-terminal start sites (Table II). Screening the very same cDNA
library using
300C as bait resulted in 137 primary LacZ+/Leu+
library cDNAs, with 23 eventually being sequenced. All but two of
these 23 were independent clones, but not a single one of them
corresponded to the
subunit of PhK. Thus, elimination of the
terminal 86 residues of
eliminated the
subunit as a target in
the cDNA library, further demonstrating that in the two-hybrid
system the C-terminal regulatory region of the
subunit of PhK
interacts with the C-terminal region of its regulatory
subunit.
View this table:
[in this window]
[in a new window]
|
Table II
Positive library clones detected by FL-BD
A rabbit skeletal muscle cDNA library was screened in the yeast
two-hybrid system using full length subunit of PhK as bait as
described under "Experimental Procedures." Positive clones were
sequenced and determined to be multiple overlapping C terminus
transcripts of PhK .
|
|
Considering that a CaM-binding regulatory region of
(8) overlaps
the region implicated above to bind
and that
-
-
complexes
can be isolated following partial dissociation of the rabbit muscle
(


)4 holoenzyme (32) raised the question of whether, during our two-hybrid screening, endogenous yeast CaM, despite
its structural and functional divergence from mammalian CaM (33, 34),
may nevertheless interact with
, giving rise to formation of ternary
(
-
-CaM), as opposed to binary (
-
), complexes. To evaluate
the feasibility of this notion, we determined whether yeast CaM could
bind and subsequently activate PhK
. When the isolated
subunit
of PhK was renatured in the presence of either purified yeast CaM or
bovine brain CaM, the yeast CaM stimulated the P-b
conversion activity of
to a similar extent as that observed with
the bovine brain isoform. The concentrations for half-maximal
activation by the yeast and bovine brain CaMs were very similar
(Ka = 0.42 ± 0.18 µM,
n = 5 versus Ka = 0.30 ± 0.10 µM, n = 3, respectively), the maximal activation by the yeast CaM was only 15%
less than by the mammalian CaM (Fig. 2).
These results indicate that in yeast, free CaM is capable of binding to
with high affinity; thus, it is possible that the observed
-
interactions identified in the two-hybrid system may actually involve
yeast CaM also and correspond to interactions occurring within the
-
-
trimer, assuming of course that
and CaM do not
exclusively compete for binding to the C-terminal region of
.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 2.
Stimulation of isolated subunit catalytic activity by CaM. PhK was renatured in
the presence of either yeast ( ) or bovine brain ( ) CaM and
assayed for enzymatic activity as described under "Experimental
Procedures." Data points represent the average of triplicate assays
with the bars indicating the S.D. Kinetic parameters given
in the text were determined by a linear regression analysis of at least
three to five separate experiments.
|
|
Formaldehyde Cross-links the C Terminus of the
Subunit to the
Subunit within the PhK Holoenzyme--
To further examine the
contact regions between the
and
subunits, we sought a very
short cross-linker that would enable us to substantiate the observed
two-hybrid
-
interactions within the context of the
(


)4 holoenzyme and, additionally, to correlate observed conformational changes between the two subunits with the
activation of PhK. Formaldehyde was chosen as the cross-linking agent
because its reaction with nucleophiles results in the insertion of but
a single methylene bridge (~2.9 Å, Ref. 35) between reactive side
chains. When PhK was cross-linked by formaldehyde, one major conjugate
with an apparent mass of 178 kDa (based on sequences an
-
dimer
has a theoretical mass of 183 kDa) was formed in large amounts (Fig.
3A). The cross-linking was
determined to be intramolecular, i.e. within a PhK
hexadecamer because the cross-linked protein coeluted with native,
hexadecameric PhK on size exclusion high pressure liquid chromatography
(data not shown), a method that we routinely use to determine the
molecularity of cross-linking (36, 37). The formation of this 178-kDa
conjugate, as followed by change in optical density, increased with
time along with a corresponding loss in density of both the
and
subunits. Furthermore, the cross-linked species cross-reacted with only
anti-
and anti-
subunit-specific mAbs by Western analysis; no
cross-reactivity was observed with the anti-
or anti-CaM (
) mAbs
(Fig. 4B). Taken together,
these data indicate the formation of an
-
dimer within the PhK
holoenzyme by the very short cross-linker formaldehyde.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Ca2+-induced changes of the
conformation of PhK. A, PhK (lane 1) was
cross-linked by formaldehyde for 30 min in the absence (lane
2) or presence of 250 µM free Ca2+
(lane 3) and resolved by SDS-PAGE. B, optical
density measurements of the Coomassie-stained - conjugates from
lanes 2 and 3 of A were determined on
a BioImage whole band analyzer. Bars represent the mean of
three experiments ± S.E.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Partial proteolysis of native and
cross-linked PhK by chymotrypsin. A, native or
cross-linked PhK was partially digested with chymotrypsin, resolved by
SDS-PAGE and stained for protein with Coomassie. Samples are as
follows: 1, native PhK; 2, native PhK digested
with chymotrypsin; 3, formaldehyde cross-linked PhK;
4, formaldehyde cross-linked PhK digested with chymotrypsin.
The 58- and 24-kDa C-terminal fragments of are indicated by
arrows. B, parallel samples were transferred to
nitrocellulose and probed with anti- , anti- , anti- , and
anti-CaM mAbs as described under "Experimental Procedures." Sample
order is identical to that of A. The two new bands
corresponding to - 1 (102 kDa) and
- 2 (68 kDa) formed by partial digestion of
cross-linked PhK are labeled. A high molecular weight, anti-
cross-reactive band is observed for native PhK digested by chymotrypsin
and is most likely derived from an - dimer in which the subunit is cross-linked to an N-terminal proteolytic fragment of (36); a small amount of cross-linking of the holoenzyme by exposure to
ultraviolet light, which occurs during typical handling and storage,
has previously been observed (52).
|
|
To localize regions of the
subunit cross-linked to the
subunit,
we relied on the highly selective proteolysis of the
subunit within
the holoenzyme by chymotrypsin, which degrades that subunit essentially
to completion without significant hydrolysis of the
,
, or
subunits (38). Partial digestion of nonactivated PhK generated major
fragments of
having apparent masses of 78, 60, 58, 30, and 24 kDa;
two fragments of
(58 and 24 kDa, Fig. 4A) have
previously been shown to cross-react with an anti-
mAb whose epitope
is known to be near the C terminus of that subunit between residues
1132-1237 (7, 20). When cross-linked enzyme was digested with
chymotrypsin, two new bands were observed,
-
1 (102 kDa) and
-
2 (68 kDa), which cross-reacted with both
the anti-
and anti-
mAbs (Fig. 4B). Based upon mass,
these new bands corresponded to the entire
subunit cross-linked to
the 58- and 24-kDa C-terminal fragments of
, respectively.
Examination of the proteolytic digestion pattern of cross-linked PhK
demonstrated corresponding losses in density of both the 58- and 24-kDa
fragments of
in the anti-
blot, as well as a significant loss in
density of the
subunit in the anti-
blot with respect to
uncross-linked proteolysed holoenzyme.
Because
-
2 was the better resolved of the two
cross-linked
-
complexes and was present in greater quantities
than
-
1, it was used for subsequent sequence
determination. N-terminal analysis of this conjugate resulted in two
sequences being identified, TRDAALPG and RRLSISTE, which correspond
exclusively to the N termini of
and the 24-kDa fragment of
,
respectively. The latter is known to result from cleavage at Phe-1014
and correspond to residues 1015-1237 of
(20), which make up the
C-terminal one-sixth of the
subunit.
Effects of Ca2+ on the Conformational Stability of the
and
Subunits--
Ca2+ is the most fundamental
activator of PhK, regulating its activity through the
subunit, an
endogenous molecule of CaM. Because the C terminus of
, known to
bind to
(8-11), was identified in this study to also associate
with
, we investigated the effect of Ca2+ on
-
dimer formation by formaldehyde. The extent of
-
dimer produced
by cross-linking the holoenzyme in the presence of Ca2+
increased by 2-fold over nonactivated PhK (Fig. 3). This enhancement of
the formation of
-
by Ca2+ corroborates the observed
two-hybrid interaction of
with the CaM-binding C terminus of
and is consistent with other cross-linking studies from our
laboratory correlating Ca2+-mediated activation of the PhK
holoenzyme with perturbations in the interaction between its
and
subunits (5-7).
Because the
-mediated effects of Ca2+ resulting in the
activation of
are concomitantly transmitted to the C-terminal
region of
, we further examined the Ca2+-induced
perturbations in this region of
by its selective cleavage with
chymotrypsin. When the PhK holoenzyme was partially digested in the
presence of Ca2+, the pattern of cleavage of the
subunit did not change; however, there was a preferential 3-fold
increase2 in the rate of
formation of the 24-kDa immunoreactive fragment of
previously shown
to result from cleavage at residue 1014. These cross-linking and
partial proteolysis results indicate that the binding of
Ca2+ ions to the
subunit of PhK causes a distinct
conformational change in the C-terminal region of its
subunit.
 |
DISCUSSION |
Whereas the catalytic
subunit of PhK is undoubtedly involved
in complex interactions with all three of its regulatory subunits, no
specific contact region between
and either of the large inhibitory
and
subunits has been determined previously. In this study, we
have identified a region within the stretch of residues 343-386 at the
C terminus of the
subunit that interacts with a region near the C
terminus of the
subunit. This region of
is of particular importance because it contains one of the two distinct, noncontiguous CaM-binding domains present in the C-terminal regulatory region of the
subunit. In a thorough study utilizing a series of 18 overlapping
25-mer peptides corresponding to the C-terminal 110-residue sequence
(amino acids 277-386) of the
subunit, Dasgupta et al. (8) identified two domains of
with nanomolar affinity for CaM:
domain N (residues 287-331) and domain C (residues 332-371). Within
domain C, the peptide with the highest affinity for CaM corresponded to
residues 342-366, which but for one residue are contained entirely
within the region of
shown herein to interact with
.
The fact that the same region within the regulatory domain of the
subunit potentially interacts with both the
(CaM) and
subunits
provides a plausible mechanism to explain how Ca2+ induces
tertiary and quaternary structural changes that are associated with
activation of the PhK holoenzyme. It has been previously suggested that
activation of PhK by various effectors occurs via a hierarchy of tiered
conformational changes, largely reflecting differing states of release
of quaternary constraint imposed by the regulatory subunits upon the
catalytic
subunit, with the most fundamental change being that
induced by Ca2+ (discussed in detail in Ref. 5). By
cross-linking analysis, it is known that structural perturbations
involving the
and
subunits occur upon activation of PhK by the
binding of Ca2+ ions to the
subunit (5-7). Therefore,
it is reasonable to hypothesize that the binding of the C-terminal
regulatory region of
to both
and
may be modulated in a
Ca2+-dependent manner; that Ca2+
affects the conformation of the very region of
found to bind
(Fig. 4) supports this hypothesis. The evidence indicates that perturbation of the
-
interactions caused by the binding of Ca2+ to
occurs concomitant with perturbation of the
-
interactions, resulting in a
-
-
communication network.
Recently, three-dimensional structures of the holoenzyme obtained by
image reconstruction of PhK particles observed by electron
microscopy ± Ca2+ (39) revealed that Ca2+
does indeed induce distinct conformational changes over a region of PhK
previously shown to be occupied by portions of its
,
, and
subunits (20, 21, 37).
Given that purified yeast CaM activates the isolated
subunit (Fig.
2), it is possible that endogenous CaM may be binding during our
two-hybrid analyses to those
constructs that have a CaM-binding
domain, and as a result, the positive interaction we observe between
full-length
and
may actually represent a trimeric
-
-
instead of a dimeric
-
complex. Typically, yeast CaM is a poor
activator of mammalian target enzymes including protein kinases (34,
40), due to its significant divergence both structurally and
functionally from mammalian CaMs; it shares only 60% identity in
primary structure (33) and does not bind Ca2+ at site IV
(41, 42). It is not surprising, however, that yeast CaM is capable of
binding to and activating PhK
because the
subunit seems to be
more sensitive to mutations in the second and third domains of CaM than
in its 1st and fourth(43); moreover, the quite dissimilar TnC also
activates
, albeit to a lesser extent than CaM (44).
If our two-hybrid interactions do, in fact, involve not only
and
, but also CaM, then additional issues arise concerning Ca2+ dependence and the interactions of the
subunit of
PhK. Because the three stable species of PhK (the hexadecameric
(


)4 holoenzyme, the
-
-
trimer, and the
-
dimer) all differ in the extent to which their activity is
dependent on Ca2+ ions, it has been suggested that
increasing enzyme complexity, i.e. progressing from
-
to
-
-
to holoenzyme, results in a progressive increase in the
Ca2+-requirement for catalytic activation of the complex
(32). Because the
-
complex readily dissociates in 8 M urea, whereas
-
-
does not, it has been further
suggested that extended interactions exist among these three subunits
in which
, besides binding
, is stabilized from dissociation by
the presence of
(45). The sum of these findings suggests that
may contribute, at least indirectly, to regulating the effects of
Ca2+ on catalysis. Our current finding that the C terminus
of
, a regulatory region that undergoes structural perturbations in
response to a variety of activating stimuli including Ca2+
(7), interacts with
within a region where it binds
supports the
existence of an intricate, Ca2+-sensitive communication
network among the
,
, and
subunits, an idea also strongly
supported by the previously mentioned structures of PhK from electron
microscopy (39). Because Ca2+-triggered communication can
flow from the
to the
subunit, then it is reasonable to expect
that some manifestation of the reverse process ought to be present, as
well. This expectation may be born out by early reports that
activation of the PhK holoenzyme by phosphorylation of its
and
subunits increases affinity of the
subunit for Ca2+
ions (46, 47).
Ca2+-dependent structural changes, similar to
those described above for PhK, have been observed in the regulation of
skeletal muscle troponin, specifically between the inhibitory region of TnI and its protein targets, actin and TnC (a CaM homologue). In
reconstituted thin filaments, the inhibitory region of TnI, which
shares remarkable sequence similarity with the C-terminal regulatory
domain of the
subunit of PhK (8, 44), interacts preferentially with
actin in the absence of Ca2+ but with TnC in the presence
of Ca2+ (48). The possibility that the inhibitory domain of
TnI and the homologous region within the
subunit of PhK share a
similar mechanism in their interactions with their respective protein targets (TnC and actin versus the
and
subunits) is
supported by the following striking structural and functional
similarities. (a) The regions of greatest sequence identity between
and TnI (amino acids 301-325 and 103-115, respectively) contain in
the case of TnI those very residues most critical for its specific interactions with actin and TnC (discussed in Ref. 44) and in the case
of
, one of its two adjacent CaM-binding domains (8). (b) TnC
activates PhK
(44). (c) Actin inhibits
-CaM and
-TnC complexes (44). (d)
inhibits actomyosin ATPase (44). The
subunit of PhK is thought to have evolved from the fusion of a protein
kinase protogene with a progenitor of exon VII of the TnI gene (44),
which encodes its inhibitory domain. The probable evolutionary link
between TnI and PhK
, the homologies that exist between them, and
our current findings suggest that in skeletal muscle the troponin
complex and the PhK holoenzyme may share related Ca2+-dependent alterations in quaternary
structure, all leading to the simultaneous stimulation by
Ca2+ ions of contraction and energy production, respectively.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant DK32953 (to G. M. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Current address: Dept. of Molecular, Cellular, and
Developmental Biology, University of Colorado, Campus Box 347, Boulder, CO 80309-0347.
§
Current address: Dept. of Pediatrics, University of Kansas
Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160.
¶
To whom correspondence should be addressed: Div. of Molecular
Biology and Biochemistry, School of Biological Sciences, University of
Missouri-Kansas City, 503 Biological Sciences Bldg., 5100, Rockhill
Rd., Kansas City, MO 64110-2499. Tel.: 816-235-2235; Fax: 816-235-5595;
E-mail: carlsongm@umkc.edu.
Published, JBC Papers in Press, February 14, 2002, DOI 10.1074/jbc.M201229200
2
Ca2+ causes a modest increase
(~20%) in the activity of chymotrypsin (49). To control for this
activation, the amount of the 24-kDa fragment generated from the
subunit was determined by densitometry and expressed as a percentage of
the total
subunit consumed. During standard digestions, the percent
of the 24-kDa fragment formed per total
consumed for
Ca2+-activated PhK was 15.4% versus 4.9% for
non-activated PhK.
 |
ABBREVIATIONS |
The abbreviations used are:
PhK, phosphorylase
b kinase;
CaM, calmodulin;
P-b, glycogen
phosphorylase-b;
BSA, bovine serum albumin;
mAb(s), monoclonal antibody(ies);
BD, binding domain;
AD, activation domain;
DTT, dithiothreitol;
TnI, troponin I;
TnC, troponin C;
FL, full-length;
SD, synthetic-defined.
 |
REFERENCES |
| 1.
|
Pickett-Gies, C. R.,
and Walsh, D. A.
(1986)
in
The Enzymes
(Boyer, P. D.
, and Krebs, E. G., eds), 3rd Ed., Vol. 17
, pp. 395-459, Academic Press, Inc., Orlando, FL
|
| 2.
|
Heilmeyer, L. M. G., Jr.
(1991)
Biochim. Biophys. Acta
1094,
168-174[Medline]
[Order article via Infotrieve]
|
| 3.
|
Brushia, R. J.,
and Walsh, D. A.
(1999)
Front. Biosci.
4,
D618-D641[Medline]
[Order article via Infotrieve]
|
| 4.
|
Nadeau, O. W.,
Sacks, D. B.,
and Carlson, G. M.
(1997)
J. Biol. Chem.
272,
26196-26201[Abstract/Free Full Text]
|
| 5.
|
Nadeau, O. W.,
Sacks, D. B.,
and Carlson, G. M.
(1997)
J. Biol. Chem.
272,
26202-26209[Abstract/Free Full Text]
|
| 6.
|
Ayers, N. A.,
Nadeau, O. W.,
Read, M. W.,
Ray, P.,
and Carlson, G. M.
(1998)
Biochem. J.
331,
137-141
|
| 7.
|
Nadeau, O. W.,
Traxler, K. W.,
Fee, L. R.,
Baldwin, B. A.,
and Carlson, G. M.
(1999)
Biochemistry
38,
2551-2559[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Dasgupta, M.,
Honeycutt, T.,
and Blumenthal, D. K.
(1989)
J. Biol. Chem.
264,
17156-17163[Abstract/Free Full Text]
|
| 9.
|
Harris, W. R.,
Malenick, D. A.,
Johnson, C. M.,
Carr, S. A.,
Roberts, G. D.,
Byles, C. A.,
Anderson, S. R.,
Heilmeyer, L. M. G., Jr.,
Fischer, E. H.,
and Crabb, J. W.
(1990)
J. Biol. Chem.
265,
11740-11745[Abstract/Free Full Text]
|
| 10.
|
James, P.,
Cohen, P.,
and Carafoli, E.
(1991)
J. Biol. Chem.
266,
7087-7091[Abstract/Free Full Text]
|
| 11.
|
Cox, S.,
and Johnson, L. N.
(1992)
Protein Eng.
5,
811-819[Abstract/Free Full Text]
|
| 12.
|
Gyuris, J.,
Golemis, E. A.,
Chertkov, H.,
and Brent, R.
(1993)
Cell
75,
791-803[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 14.
|
Ausembel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1996)
Current Protocols in Molecular Biology
, John Wiley and Sons, New York, NY
|
| 15.
|
King, M. M.,
and Carlson, G. M.
(1981)
J. Biol. Chem.
256,
11058-11064[Abstract/Free Full Text]
|
| 16.
|
Paudel, H. K.,
and Carlson, G. M.
(1987)
J. Biol. Chem.
262,
11912-11915[Abstract/Free Full Text]
|
| 17.
|
Fischer, E. H.,
and Krebs, E. G.
(1958)
J. Biol. Chem.
231,
65-71[Free Full Text]
|
| 18.
|
Kastenschmidt, L. L.,
Kastenschmidt, J.,
and Helmreich, E.
(1968)
Biochemistry
7,
3590-3608[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Cohen, P.
(1973)
Eur. J. Biochem.
34,
1-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Wilkinson, D. A.,
Marion, T. N.,
Tillman, D. M.,
Norcum, M. T.,
Hainfeld, J. F.,
Seyer, J. M.,
and Carlson, G. M.
(1994)
J. Mol. Biol.
235,
974-982[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Wilkinson, D. A.,
Norcum, M. T.,
Fitzgerald, T. J.,
Marion, T. N.,
Tillman, D. M.,
and Carlson, G. M.
(1997)
J. Mol. Biol.
265,
319-329[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Ayers, N. A.,
Wilkinson, D. A.,
Fitzgerald, T. J.,
and Carlson, G. M.
(1999)
J. Biol. Chem.
274,
35583-35590[Abstract/Free Full Text]
|
| 23.
|
Geitz, D., St.,
Jean, A.,
Woods, R. A.,
and Schiestl, R. H.
(1992)
Nucleic Acids Res.
20,
1425[Free Full Text]
|
| 24.
|
Law, D. J.,
Allen, D. L.,
and Tidball, J. G.
(1994)
J. Cell Sci.
107,
1477-1483[Abstract]
< |